Blood Screening Market

Blood Screening Market by Products (Reagent and Instrument), Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay & Enzyme Immunoassay, Next-generation Sequencing, and Western Blotting), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1023
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 125
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global blood screening market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing blood donations, increase in the incidence of infectious diseases, and government initiatives.

Blood screening involves a process of examining the blood sample to ensure the safety of blood units. Screening donated blood and quarantining of blood or blood components are key steps that is mainly followed during the screening process. They are either released for clinical or manufacturing use or discarded based on the screening findings. The main purpose of the screening is to detect infection markers in the blood before they are sent for clinical or laboratory use so that any infected blood or blood components are discarded. The screening tests are widely adopted for examining donated blood to check for numerous infectious diseases such as HBV, HCV, HIV-1, and HIV-2. All blood tests are recorded in laboratories using defined processes and these tests are used to track a variety of diseases, health problems, and other clinical disorders including cancer and infections.

Global Blood Screening Market Summary

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing initiatives by governments and non-governmental organizations for spreading the awareness of blood donation and screening before blood transfusion are projected to boost the market growth during the forecast period.
  • Increased adoption rate of screening for hepatitis B, hepatitis C, and HIV viruses is projected to fuel the market growth during the forecast period.
  • Affordability and increasing applications of nucleic acid amplification test (NAT) for blood screening are projected to propel the market growth during the forecast period.
  • Lack of skilled people and availability of alternative technologies such as digital immunoassay possess as key challenges that can impede the market growth during the forecast period.
  • Increasing technological advancement and ongoing R&D programs for developing innovative screening devices are projected to create lucrative opportunities for the market players.

Scope of the Report

The report on the global blood screening market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Blood Screening Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Reagent and Instrument) and Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay & Enzyme Immunoassay, Next-Generation Sequencing, and Western Blotting)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Becton, Dickinson and Company; Thermo Fisher Scientific.; Ortho-Clinical Diagnostics, Inc.; Grifols; Danaher Corporation (Beckman Coulter); Abbott Laboratories; Bio-Rad Laboratories; Inc., F. Hoffmann-La Roche Ltd.; and Siemens Healthineers.

 

Market Segment Insights

Reagent segment is expected to account for a key share of the market
Based on products, the blood screening market is bifurcated into reagent and instrument. The reagent segment is expected to account for a key share of the market during the forecast period owing to its high accuracy and specificity in detecting various elements in very small sample. Furthermore, reagents are affordable for customers and providing a good return on investment for vendors. On the other hand, the instrument segment is anticipated to expand at a rapid pace during the forecast period due to introduction of several diagnostic devices in the market and rising approval of such instruments.

Global Blood Screening Market By Product

NAT segment is expected to constitute a key market share
In terms of technology, the market is segmented into nucleic acid amplification test (NAT), ELISA, chemiluminescence immunoassay & enzyme immunoassay, next-generation sequencing, and western blotting. The NAT segment is expected to constitute a key share of the market during the forecast period owing to its high sensitivity and specificity for viral nucleic acid. The results for nucleic acid from this test are rapid compared to other screening techniques; thus, shortening the window of infection for HBV, HCV, and HIV.

On the other hand, the ELISA segment is anticipated to expand at a rapid pace during the forecast period due to continuous efforts for increasing the specificity, its low cost compared to NAT, increasing demand from Asia Pacific due to rising prevalence of infectious diseases.

Global Blood Screening Market By Technology

North America is anticipated to dominate the market
On the basis of regions, the blood screening market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at an impressive CAGR during the forecast period. The regional market growth can be attributed to the existence of major industry players, higher utilization of blood screening processes, rigorous FDA transfusion regulations, and higher patient affordability.

On the other hand, the market in Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to rising public awareness about blood donation, increased patient affordability, and a growing emphasis of major industry participants on emerging countries in the region. China, Japan, India, Singapore, and Australia are holding key market shares in the region.

Global Blood Screening Market By Region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Screening Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Blood Screening Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Blood Screening Market - Supply Chain
  4.5. Global Blood Screening Market Forecast
     4.5.1. Blood Screening Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Blood Screening Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Blood Screening Market Absolute $ Opportunity
5. Global Blood Screening Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Blood Screening Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Blood Screening Demand Share Forecast, 2019-2026
6. North America Blood Screening Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Blood Screening Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Blood Screening Demand Share Forecast, 2019-2026
7. Latin America Blood Screening Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Blood Screening Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Blood Screening Demand Share Forecast, 2019-2026
8. Europe Blood Screening Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Blood Screening Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Blood Screening Demand Share Forecast, 2019-2026
9. Asia Pacific Blood Screening Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Blood Screening Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Blood Screening Demand Share Forecast, 2019-2026
10. Middle East & Africa Blood Screening Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Blood Screening Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Blood Screening Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Blood Screening Market: Market Share Analysis
  11.2. Blood Screening Distributors and Customers
  11.3. Blood Screening Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Becton, Dickinson and Company
     11.4.2. Thermo Fisher Scientific.
     11.4.3. Ortho-Clinical Diagnostics, Inc.
     11.4.4. Grifols
     11.4.5. Danaher Corporation (Beckman Coulter)
     11.4.6. Abbott Laboratories
     11.4.7. Bio-Rad Laboratories, Inc.
     11.4.8.
Segments Covered in the Report
The global blood screening market has been segmented on the basis of

Products
  • Reagent
  • Instrument
Technology
  • Nucleic Acid Amplification Test (NAT)
  • ELISA
  • Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA)
  • Next-Generation Sequencing (NGS)
  • Western Blotting
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific.
  • Ortho-Clinical Diagnostics, Inc.
  • Grifols
  • Danaher Corporation (Beckman Coulter)
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers

Key players competing in the blood screening market are Becton, Dickinson and Company; Thermo Fisher Scientific.; Ortho-Clinical Diagnostics, Inc.; Grifols; Danaher Corporation (Beckman Coulter); Abbott Laboratories; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd.; and Siemens Healthineers.

Some of these players are widely engaged in main strategies for expanding their market shares and positions by involving in the process of new products development and partnerships or collaborations for business expansion and commercialization of their products.

Global Blood Screening Market By Key Players

Buy Report